Related Experiment Video

Updated: Mar 2, 2026

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

8.4K

Selective targeting of point-mutated KRAS through artificial microRNAs

Mario Acunzo1,2, Giulia Romano3,2, Giovanni Nigita3

  • 1Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210; carlo.croce@osumc.edu mario.acunzo@vcuhealth.org.

Proceedings of the National Academy of Sciences of the United States of America
|May 10, 2017
PubMed

Insights

Artificial microRNAs (amiRNAs) selectively target mutated KRAS, a cancer-driving gene, without affecting healthy genes. This approach offers a more efficient strategy for cancer therapy compared to traditional methods.

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • Mutated protein-coding genes, particularly KRAS, are key drivers of cancer development.
  • Current cancer therapies often struggle to selectively target mutated genes, leading to side effects.

Purpose of the Study:

  • To develop a novel therapeutic strategy using artificial microRNAs (amiRNAs) to specifically target point-mutated KRAS.
  • To demonstrate the selective targeting of mutated KRAS without affecting wild-type KRAS.

Main Methods:

  • Design and application of artificial microRNA-like molecules (amiRNAs).
  • Utilizing perfect complementarity in the microRNA seed region for target specificity.
  • In vitro and in vivo validation of amiRNA efficacy and selectivity.

Main Results:

  • Successfully designed amiRNAs to specifically target point-mutated KRAS.
  • Demonstrated selective inhibition of mutated KRAS in both in vitro and in vivo models.
  • Showcased superior efficiency compared to siRNA-like approaches.

Conclusions:

  • Artificial microRNAs offer a precise and efficient method for targeting oncogenic KRAS mutations.
  • This strategy holds promise for developing more effective and less toxic cancer treatments.
  • The seed region complementarity model enhances the specificity of microRNA-based therapeutics.
Keywords:
KRASRNAiartificial microRNA

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.8K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

3.0K

Related Concept Videos

In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
17.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K